Targacept (TRGT) -15% premarket after the antidepressant it was testing with AstraZeneca (AZN)...

|By:, SA News Editor

Targacept (TRGT) -15% premarket after the antidepressant it was testing with AstraZeneca (AZN) failed in its last two late-stage studies, ending plans to seek regulatory approval. The two companies said on Dec. 20 the drug hadn’t met its target in a late-stage trial, and the latest failure was the final of four trials on the therapy.